Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127589201 | 12758920 | 1 | I | 20160815 | 0 | 20160919 | 20160919 | DIR | US-FDA-350946 | FDA-CTU | 41.00 | YR | F | N | 65.25000 | KG | 20160919 | N | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127589201 | 12758920 | 1 | PS | BOTOX | ONABOTULINUMTOXINA | 1 | Subcutaneous | OTHER STRENGTH:;OTHER DOSE:;OTHER FREQUENCY:EVERY 12 WEEKS.;OTHER ROUTE: | N | D | 0 | ||||||||
| 127589201 | 12758920 | 3 | C | SAVELLA | MILNACIPRAN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 5 | C | ARMOUR THYROID | THYROID, PORCINE | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 7 | C | TOPAMAX | TOPIRAMATE | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 9 | C | FIORICET | ACETAMINOPHENBUTALBITALCAFFEINE | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 11 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 13 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 15 | C | MAXALT | RIZATRIPTAN BENZOATE | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 17 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 19 | C | 5-HTP | OXITRIPTAN | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 21 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 23 | C | IRON | IRON | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 25 | C | BIOTIN | BIOTIN | 1 | 0 | ||||||||||||
| 127589201 | 12758920 | 27 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127589201 | 12758920 | 1 | Migraine |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127589201 | 12758920 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127589201 | 12758920 | Abdominal pain upper | |
| 127589201 | 12758920 | Anxiety | |
| 127589201 | 12758920 | Decreased appetite | |
| 127589201 | 12758920 | Diarrhoea | |
| 127589201 | 12758920 | Facial paralysis | |
| 127589201 | 12758920 | Fatigue | |
| 127589201 | 12758920 | Influenza | |
| 127589201 | 12758920 | Malaise | |
| 127589201 | 12758920 | Migraine | |
| 127589201 | 12758920 | Muscular weakness | |
| 127589201 | 12758920 | Myalgia | |
| 127589201 | 12758920 | Nausea | |
| 127589201 | 12758920 | Neck pain | |
| 127589201 | 12758920 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127589201 | 12758920 | 1 | 20160815 | 20160815 | 0 |